Sandu Pharmaceuticals has informed that it has enclosed Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for half year ended 31.03.2021
The above information is a part of company’s filings submitted to BSE.